|Articles|November 2, 2021
Analyzing Raw Material for Oligonucleotide Synthesis
Author(s)Agilent
This application demonstrates excellent performance in method development for the analysis of raw materials for oligonucleotide synthesis using a biocompatible UHPLC.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
New Cellevate Nanofiber Microcarriers Aim to Transform Vaccine Manufacturing Processes
2
Overcoming Funding Challenges and Maintaining Optimism in CGTs (Part 1)
3
In KPMG's CEO Outlook, AI, Regulatory Demands, and Supply Chain Risk Rank High
4
Everything to Know About Cell and Gene Therapy in 2025
5
